Versigent PLC (VGNT) Stock Price & Analysis
Versigent PLC (VGNT) closed at USD 43.71 on Thursday, October 15, 2026, up 2.70% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 42.56; the Oct 15, 2026 session ranged USD 41.56–43.91 on volume of 834,117 shares. Market capitalization is $3.10B, with a 52-week range of USD 26.34–50.89 (NYQ). Source: Nexqual, retrieved October 16, 2026 at 05:21 UTC.
Also available as compact Markdown for AI agents: nexqual.com/VGNT.md
Key facts (VGNT)
- Valuation: P/E 7.8x, EV/EBITDA 6.4x, net debt $1.67B.
- 2 of 80 tracked superinvestors hold VGNT (13F, Q2 2026): 2 new, 0 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 2 Form 4 filings, $10.1M; 0 not under a Rule 10b5-1 plan ($0K).
- Analysts: Buy (mean 1.70 on a 1–5 scale) (10 analysts), mean target USD 56.78 (range 53–65).
- Total return with dividends: 1Y +45.1% vs S&P 500 +18.1%; 5Y +45.1% vs S&P 500 +85.1%.
- Next earnings: 2026-11-04, EPS estimate USD 1.72, revenue estimate $2.42B.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (VGNT)
P/E 7.8x · P/S 0.3x · EV/EBITDA 6.4x · EV/Sales 0.5x · P/FCF 16.5x · P/B 36.4x · FCF yield 6.07% · Earnings yield 12.85% · Net debt $1.67B · EV $4.77B
Superinvestors (SEC 13F-HR, Q2 2026) (VGNT)
2 of 80 tracked investors hold VGNT. Change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Alex Roepers | Atlantic Investment Management | 2.64% | $5.1M | New position |
| David Einhorn | Greenlight Capital | 2.45% | $95.7M | New position |
Insider sales (SEC Form 4, open-market, last ~7 months) (VGNT)
2 of 2 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan |
|---|---|---|---|---|---|---|
| 2026-10-07…2026-10-08 | Clark Kevin P | Director | 97,278 | $4.3M | 77.9% | Yes (adopted June 3, 2026) |
| 2026-09-08…2026-09-09 | Clark Kevin P | Director | 122,722 | $5.7M | 49.6% | Yes (adopted June 3, 2026) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Analysts (VGNT)
Consensus Buy (mean 1.70 on a 1–5 scale), 10 analysts; mean target USD 56.78 (low 53, high 65).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | RBC Capital | Target raised | Outperform | $52 → $53 |
| 2026-10-06 | Goldman Sachs | Target lowered | Buy | $59 → $58 |
| 2026-08-13 | Argus Research | Target raised | Buy | $50 → $54 |
| 2026-08-10 | Evercore ISI Group | Target raised | Outperform | $60 → $65 |
| 2026-08-05 | TD Cowen | Target raised | Buy | $49 → $58 |
| 2026-08-05 | RBC Capital | Upgrade | Sector Perform → Outperform | $41 → $52 |
| 2026-08-05 | Wells Fargo | Target raised | Overweight | $48 → $56 |
| 2026-07-20 | Goldman Sachs | Initiated | Buy | $48 |
| 2026-07-13 | RBC Capital | Target raised | Sector Perform | $34 → $41 |
| 2026-07-09 | UBS | Target lowered | Buy | $58 → $55 |
| 2026-07-08 | Deutsche Bank | Upgrade | Hold → Buy | $50 |
| 2026-06-25 | Wells Fargo | Target raised | Overweight | $42 → $48 |
Total return (dividends reinvested) (VGNT)
| 1Y (from 2026-03-27) | 5Y (from 2026-03-23) | |
|---|---|---|
| Total return | +45.1% | +45.1% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | — | — |
| Volatility (annualized) | 56.7% | 40.0% |
| Max drawdown | -21.5% (Jun 2026→Jun 2026) | -15.6% (Jun 2026→Jul 2026) |
Key Statistics (as of October 16, 2026 at 05:21 UTC)
| Price | USD 43.71 |
|---|---|
| Change | ▲ 2.70% (up) |
| Previous Close | USD 42.56 |
| Open | USD 42.23 |
| Day Range | USD 41.56 – 43.91 |
| 52-Week Range | USD 26.34 – 50.89 |
| Volume | 834,117 shares |
| Market Cap | $3.10B |
| Exchange | NYQ |
Technical Analysis (VGNT)
Nexqual's technical model rates VGNT "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:21 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 41.66 (neutral) |
| vs SMA50 | Below (USD 46.15) |
| MACD | -0.73 (negative) |
Analyst Ratings (VGNT)
Wall Street analysts rate VGNT "Buy" based on 10 analysts, with a mean price target of USD 56.78 (range USD 53–65), per Nexqual as of October 16, 2026 at 05:21 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 10 |
| Mean Target | USD 56.78 |
| High Target | USD 65 |
| Low Target | USD 53 |
| Buy / Hold / Sell | 10 / 0 / 0 |
Earnings (VGNT)
| Next Earnings Date | 2026-11-04 |
|---|---|
| EPS Estimate | USD 1.72 |
| Revenue Estimate | $2.42B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.92 vs est 1.44 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financials & Fundamentals (VGNT)
| Total Revenue | $9.24B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +10.80% |
| Gross Margin | +12.35% |
| Operating Margin | +8.80% |
| Profit Margin | +5.65% |
| Debt / Equity | 8.53 |
| Current Ratio | 1.4 |
| Total Cash | $554.00M |
| Total Debt | $2.42B |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financial Health Score (VGNT)
Nexqual rates Versigent PLC's overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:21 UTC.
| Growth | Solid — Revenue +11% YoY (latest Q) |
|---|---|
| Profitability | Weak — Gross margin 12%, operating 9% |
| Balance Sheet | Critical — $554M cash vs $2.42B debt |
| Cash Flow | Solid — Operating cash flow $645M (TTM) |
| Efficiency | Mixed — No data |
Ownership (VGNT)
| Insider Ownership | +0.71% |
|---|---|
| Institutional Ownership | +103.00% |
| Shares Outstanding | 70.84M |
| Float | 70.26M |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Leadership (VGNT)
Versigent PLC is led by Joseph T. Liotine (age 52), CEO & Director, per Nexqual as of October 16, 2026 at 05:21 UTC.
| CEO & Director | Joseph T. Liotine (age 52) |
|---|---|
| Chief Financial Officer | Douglas R. Ostermann (age 57) |
| Vice President of Investor Relations | Erin Banyas |
| Vice President of Marketing & Corporate Communications | Annalisa Esposito Bluhm |
| Vice President of Global Sales | Paul Moore |
Major Backers & Investors (VGNT)
Notable institutional backers of Versigent PLC include Alliancebernstein L.P., FMR, LLC, DME Capital Management, LP, according to Nexqual as of October 16, 2026 at 05:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Alliancebernstein L.P. | 4.74% |
| FMR, LLC | 3.91% |
| DME Capital Management, LP | 3.22% |
| NORGES BANK | 2.13% |
| Capital International Investors | 1.85% |
| SmallCap World Fund Inc | 1.8% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 24.48% |
| Vanguard Group | 18.6% |
| State Street | 4.05% |
| Geode Capital | 2.59% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ATMU | Atmus Filtration Technologies I | USD 43.98 | ▲ 0.5% |
| DORM | Dorman Products, Inc. | USD 123.63 | ▲ 0.24% |
| GTX | Garrett Motion Inc. | USD 24.45 | ▼ 5.18% |
| GNTX | Gentex Corporation | USD 21.11 | ▲ 1.15% |
| LKQ | LKQ Corporation | USD 22.36 | ▲ 0.81% |
| LEA | Lear Corporation | USD 121.49 | ▲ 1.58% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:21 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt